Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Find generic entry opportunities
Manage your formulary budget
Proactively manage your pharmacy inventory
|Title:||Metered dose inhaler for albuterol|
|Abstract:||A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally a blend of one or more fluorocarbon polymers in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising albuterol or a physiologically acceptable salt thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.|
|Inventor(s):||Ashurst; Ian Carl (Ware, GB), Herman; Craig Steven (Raleigh, NC), Li-Bovet; Li (Scotch Plains, NJ), Riebe; Michael Thomas (Raleigh, NC)|
|Assignee:||Glaxo Wellcome Inc. (Research Triangle Park, NC) Glaxo Group Limited (Greenford Middlesex, GB)|
Patent Claim Types:|
see list of patent claims
|Formulation; Compound; Delivery; Device; Use; Composition;|
Field: Medical technology
Back Citations: 105th percentile
Forward Citations: 14th percentile
|Patent Number||Expiration Date|
|6,131,566||October 17, 2012|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||791||► subscribe|
|African Regional IP Organization (ARIPO)||9701114||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.